Literature DB >> 9494834

Ehrlichiosis.

C L Fritz1, C A Glaser.   

Abstract

HGE and HME have been recognized as distinct clinical conditions for only 5 and 10 years, respectively, and much information regarding their ecology and epidemiology remains uncertain. The nonspecific character of the illness complicates this incomplete knowledge, as an unknown percentage of infections are likely misdiagnosed. Ehrlichiosis should be considered in any patient presenting with flu-like illness and history of a tick bite. Although expanding, diagnostic support for human ehrlichioses is currently limited to a few regional academic and public health laboratories. Healthcare providers should educate themselves regarding the clinical presentation of ehrlichioses and the availability of diagnostic resources in their area.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9494834     DOI: 10.1016/s0891-5520(05)70413-x

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  7 in total

1.  Quantitative evaluation of ehrlichial burden in horses after experimental transmission of human granulocytic Ehrlichia agent by intravenous inoculation with infected leukocytes and by infected ticks.

Authors:  N Pusterla; C M Leutenegger; J S Chae; H Lutz; R B Kimsey; J S Dumler; J E Madigan
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Renal, hepatic, and marrow dysfunction in a patient with chronic renal insufficiency.

Authors:  Rebecca C Brady; John J Bissler
Journal:  Pediatr Nephrol       Date:  2003-02-12       Impact factor: 3.714

3.  Incidence of Rocky Mountain spotted fever among American Indians in Oklahoma.

Authors:  J H McQuiston; R C Holman; A V Groom; S F Kaufman; J E Cheek; J E Childs
Journal:  Public Health Rep       Date:  2000 Sep-Oct       Impact factor: 2.792

4.  Experimental inoculation with human granulocytic Ehrlichia agent derived from high- and low-passage cell culture in horses.

Authors:  N Pusterla; J E Madigan; K M Asanovich; J S Chae; E Derock; C M Leutenegger; J B Pusterla; H Lutz; J S Dumler
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

5.  Serologic testing for human granulocytic ehrlichiosis at a national referral center.

Authors:  J A Comer; W L Nicholson; J G Olson; J E Childs
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

Review 6.  Ehrlichia chaffeensis: a prototypical emerging pathogen.

Authors:  Christopher D Paddock; James E Childs
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

7.  Ehrlichia chaffeensis infections among HIV-infected patients in a human monocytic ehrlichiosis-endemic area.

Authors:  Thomas R Talbot; James A Comer; Karen C Bloch
Journal:  Emerg Infect Dis       Date:  2003-09       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.